246 related articles for article (PubMed ID: 14628479)
1. [Research progress on mechanism of cisplatin ototoxicity and protective agents against the ototoxic effects].
Liao YJ; Tang H
Sheng Li Ke Xue Jin Zhan; 2003 Jul; 34(3):266-9. PubMed ID: 14628479
[No Abstract] [Full Text] [Related]
2. Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats.
Huang X; Whitworth CA; Rybak LP
Otol Neurotol; 2007 Sep; 28(6):828-33. PubMed ID: 17450108
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin ototoxicity in the Sprague Dawley rat evaluated by distortion product otoacoustic emissions.
Hatzopoulos S; Di Stefano M; Campbell KC; Falgione D; Ricci D; Rosignoli M; Finesso M; Albertin A; Previati M; Capitani S; Martini A
Audiology; 2001; 40(5):253-64. PubMed ID: 11688544
[TBL] [Abstract][Full Text] [Related]
4. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity.
Cooper LB; Chan DK; Roediger FC; Shaffer BR; Fraser JF; Musatov S; Selesnick SH; Kaplitt MG
Otol Neurotol; 2006 Jun; 27(4):484-90. PubMed ID: 16791039
[TBL] [Abstract][Full Text] [Related]
5. Effect of protective agents against cisplatin ototoxicity.
Rybak LP; Husain K; Morris C; Whitworth C; Somani S
Am J Otol; 2000 Jul; 21(4):513-20. PubMed ID: 10912697
[TBL] [Abstract][Full Text] [Related]
6. Comparison of five agents in protecting the cochlea against the ototoxic effects of cisplatin in the hamster.
Kaltenbach JA; Church MW; Blakley BW; McCaslin DL; Burgio DL
Otolaryngol Head Neck Surg; 1997 Nov; 117(5):493-500. PubMed ID: 9374173
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of N-acetylcysteine against cisplatin ototoxicity in rats: a study with hearing tests and scanning electron microscopy.
Somdaş MA; Güntürk İ; Balcıoğlu E; Avcı D; Yazıcı C; Özdamar S
Braz J Otorhinolaryngol; 2020; 86(1):30-37. PubMed ID: 30268784
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent protection on cisplatin-induced ototoxicity - an electrophysiological study on the effect of three antioxidants in the Sprague-Dawley rat animal model.
Lorito G; Hatzopoulos S; Laurell G; Campbell KC; Petruccelli J; Giordano P; Kochanek K; Sliwa L; Martini A; Skarzynski H
Med Sci Monit; 2011 Aug; 17(8):BR179-186. PubMed ID: 21804453
[TBL] [Abstract][Full Text] [Related]
9. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
[TBL] [Abstract][Full Text] [Related]
10. Effect of high-dose cisplatin on auditory brainstem responses and otoacoustic emissions in laboratory animals.
Sockalingam R; Freeman S; Cherny TL; Sohmer H
Am J Otol; 2000 Jul; 21(4):521-7. PubMed ID: 10912698
[TBL] [Abstract][Full Text] [Related]
11. Comparative ototoxicity of cisplatin during acute and chronic treatment.
Saito T; Aran JM
ORL J Otorhinolaryngol Relat Spec; 1994; 56(6):315-20. PubMed ID: 7838482
[TBL] [Abstract][Full Text] [Related]
12. Otoacoustic emissions: an approach for monitoring aminoglycoside-induced ototoxicity.
Hotz MA; Harris FP; Probst R
Laryngoscope; 1994 Sep; 104(9):1130-4. PubMed ID: 8072361
[TBL] [Abstract][Full Text] [Related]
13. Astragalosides reduce cisplatin ototoxicity in guinea pigs.
Xiong M; He Q; Wang J; Lai H
ORL J Otorhinolaryngol Relat Spec; 2011; 73(3):131-6. PubMed ID: 21494054
[TBL] [Abstract][Full Text] [Related]
14. [Experimental studies of the protective effect of deferoxamine mesilate on cisplatin induced toxicity].
Watanabe H; Kanno H
Nihon Jibiinkoka Gakkai Kaiho; 1998 Aug; 101(8):967-78. PubMed ID: 9778942
[TBL] [Abstract][Full Text] [Related]
15. The comparative effects of sodium thiosulfate, diethyldithiocarbamate, fosfomycin and WR-2721 on ameliorating cisplatin-induced ototoxicity.
Church MW; Kaltenbach JA; Blakley BW; Burgio DL
Hear Res; 1995 Jun; 86(1-2):195-203. PubMed ID: 8567417
[TBL] [Abstract][Full Text] [Related]
16. The role of antioxidants in protection from ototoxic drugs.
Sergi B; Fetoni AR; Ferraresi A; Troiani D; Azzena GB; Paludetti G; Maurizi M
Acta Otolaryngol Suppl; 2004 May; (552):42-5. PubMed ID: 15219046
[TBL] [Abstract][Full Text] [Related]
17. Transtympanic Ringer's lactate application in the prevention of cisplatinum-induced ototoxicity in a chinchilla animal model.
Munguia R; Sahmkow SI; Funnell WR; Daniel SJ
Otolaryngol Head Neck Surg; 2010 Jul; 143(1):134-40. PubMed ID: 20620632
[TBL] [Abstract][Full Text] [Related]
18. Similar pharmacokinetics and differential ototoxicity after administration with cisplatin and transplatin in guinea pigs.
Saito T; Zhang ZJ; Yamada T; Yamamoto T; Shibamori Y; Saito H
Acta Otolaryngol; 1997 Jan; 117(1):61-5. PubMed ID: 9039483
[TBL] [Abstract][Full Text] [Related]
19. Assessing cisplatin-induced ototoxicity and otoprotection in whole organ culture of the mouse inner ear in simulated microgravity.
Tropitzsch A; Arnold H; Bassiouni M; Müller A; Eckhard A; Müller M; Löwenheim H
Toxicol Lett; 2014 Jun; 227(3):203-12. PubMed ID: 24709139
[TBL] [Abstract][Full Text] [Related]
20. Neurochemistry of the peripheral and central auditory system after ototoxic drug exposure: implications for tinnitus.
Rybak LP
Int Tinnitus J; 2005; 11(1):23-30. PubMed ID: 16419684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
